Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | Chief Financial Officer, | February 14, 2020 | February 14, 2020 |
| Pennant Group, Inc.PNTG · Entity 4774 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date February 14, 2020 · Filed February 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,274 |
Ending reported balance
After 2020-02-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-02-14 · Exercise / conversion · Acquired 1,006 · Balance 16,803 Row 2 · 2020-02-14 · Tax withholding · Disposed 529 · Balance 16,274 |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2021-02-15 | Direct | 1,005 |
Reported balance
After 2020-02-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-02-14 · Exercise / conversion · Disposed 1,006 · Balance 1,005 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: There is neither a purchase price nor an exercise price for the PRSUs. F3: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on February 15 of the first, second, and third year following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: There is neither a purchase price nor an exercise price for the PRSUs.
F3: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on February 15 of the first, second, and third year following the year of grant.
Pennant Group, Inc.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,935 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 2,400 · Balance 58,935 F1: These shares vest in three annual installments beginning July 15, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares vest in three annual installments beginning July 15, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 13,850 | $43.12 Strike: $43.12 | $597,212.00 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · derivative · entry 7 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Underlying: Common Stock · 13,850 shares Expires 2021-02-02 F7 · price: Transaction is the exercise of a derivative security; see Column 2. F6 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,700 | $122.08 | $329,602.50 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $122.01 to $122.18, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 11,150 | $121.69 | $1,356,861.34 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,081 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.99, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 13,850 | $43.12 | $597,212.00 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,231 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,186 | $122.08 | $266,875.19 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $122.04 to $122.24, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 12,490 | $121.75 | $1,520,632.52 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,567 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $121.04 to $122.02, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 14,676 | $43.62 | $640,167.12 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,057 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.